Pharmaceuticals

Vasopressin Industry Growth Insights: Revenue Forecast to 2030

February 20, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the vasopressin market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Vasopressin Market between 2026 and 2030?

The vasopressin market has experienced significant expansion in recent years. It is anticipated to grow from $1.57 billion in 2025 to $1.79 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.0%. This historic period of growth can be credited to its established function in antidiuretic hormone deficiency, widespread application in gastrointestinal bleeding, the increasing number of intensive care units, its proven effectiveness in managing shock, and the expansion of hospital emergency services.

The vasopressin market size is anticipated to experience substantial growth in the upcoming period. Its value is projected to reach $2.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. This expansion over the forecast period is attributed to several factors, including the increasing incidence of septic shock, a rise in ICU admissions, advancements in critical care protocols, growing awareness of hormonal disorders, and the expansion of emergency medicine infrastructure. Prominent trends expected during this period involve the rising use of vasopressin in critical care and shock management, increasing demand within sepsis and intensive care units, enhanced adoption in hormonal deficiency treatment, the expansion of injectable hormone therapies, and a greater focus on emergency care applications.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16207&type=smp

Which Drivers Are Expected To Impact The Vasopressin Market During The Forecast Period?

The increasing incidence of diabetes is projected to stimulate the expansion of the vasopressin market in the coming years. Diabetes is a long-term health condition marked by high blood glucose levels, stemming from the body’s impaired capacity to produce or effectively utilize insulin. The widespread occurrence of diabetes can be attributed to escalating obesity rates, mental health issues and stress, and inherited factors. Vasopressin is essential for the management of central diabetes insipidus, as it aids in re-establishing normal water equilibrium and lessening symptoms such as frequent urination and intense thirst. For instance, in June 2024, data from the National Health Service (NHS), a UK-based government department, showed an increase in diabetes cases among individuals under 40, rising from 173,166 in 2022 to 216,440 in 2023. This considerable rise underscores a worrisome trend in this age group, reflecting a swift escalation in diabetes prevalence within younger demographics. Thus, the expanding prevalence of diabetes is a key driver for the vasopressin market.

Which Segments Are Driving Activity In The Vasopressin Market?

The vasopressin market covered in this report is segmented –

1) By Product Type: Intravenous Injection, Intramuscular Injection, Subcutaneous Injection

2) By Application: Anti-Diuretic Hormone Deficiency, Vasodilatory Shock, Gastrointestinal Bleeding, Ventricular Tachycardia And Fibrillation

3) By End-User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Intravenous Injection: Standard Iv Vasopressin Injection, High-Dose Iv Vasopressin Injection, Iv Vasopressin For Sepsis And Shock Treatment, Iv Vasopressin For Post-Operative Care

2) By Intramuscular Injection: Standard Im Vasopressin Injection, Intramuscular Vasopressin For Hormonal Imbalance, Vasopressin Injection For Acute Hemorrhage Control

3) By Subcutaneous Injection: Subcutaneous Vasopressin For Diabetes Insipidus

What Trends Are Expected To Impact The Competitive Landscape Of The Vasopressin Market?

Leading companies in the vasopressin market are creating advanced solutions, including higher-concentration ready-to-use vasopressin formulations, to enhance dosing accuracy, decrease preparation time, and boost safety within critical-care environments. This type of vasopressin is an intravenous premixed solution with an elevated unit-per-mL ratio, removing the necessity for bedside mixing, facilitating quicker treatment initiation, and reducing administration mistakes when treating vasodilatory shock. An example of this innovation is Baxter Healthcare Corporation, a pharmaceutical and medical device company from the US, which gained FDA approval in March 2024 for Vasopressin in 0.9% Sodium Chloride Injection, 50 units/50 mL (1 unit/mL). This particular formulation is a concentrated, ready-to-use vasopressin product with a consistent 1-unit/mL strength, which lessens the need for frequent bag replacements. It also comes as a premixed single-dose format, doing away with compounding steps, and is compatible with standard infusion systems, thereby simplifying its use in emergency and intensive-care settings.

Which Key Market Players Are Investing In Expansion And Innovation Within The Vasopressin Market?

Major companies operating in the vasopressin market are Pfizer Inc., Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Amphastar Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals Inc., Eagle Pharmaceuticals Inc., Par Pharmaceutical Holdings Inc., Fresenius Kabi, Nordic Pharma Inc., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Apotex Inc., Amneal Pharmaceuticals Inc., Bachem Holding AG, BCN Peptides SA, Laboratorio ELEA S.A.C.I.F. y A., Hainan Zhonghe Pharmaceutical Co. Ltd., Cumberland Pharmaceuticals Inc., AMOMED Pharma GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/vasopressin-global-market-report

Which Regions Are Poised For Strategic Growth In The Vasopressin Market?

North America was the largest region in the vasopressin market in 2025. The regions covered in the vasopressin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Vasopressin Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16207&type=smp

Browse Through More Reports Similar to the Global Vasopressin Market 2026, By The Business Research Company

Vasopressin Market Report 2026

https://www.thebusinessresearchcompany.com/report/vasopressin-global-market-report

Vasodilators Market Report 2026

https://www.thebusinessresearchcompany.com/report/vasodilators-global-market-report

Peripheral Vasodilator Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-vasodilator-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795